Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NeOnc Technologies Holdings, Inc. ( (NTHI) ) has issued an update.
On June 5, 2025, NeOnc Technologies Holdings, Inc. appointed Josh Neman as Chief Clinical Officer. Mr. Neman, with a background in neurological surgery and leadership roles at the University of Southern California, will receive a base salary of $165,000 and participate in the company’s 2023 Equity Incentive Plan. This strategic appointment is expected to enhance the company’s clinical operations and strengthen its position in the industry.
More about NeOnc Technologies Holdings, Inc.
Average Trading Volume: 73,978
For detailed information about NTHI stock, go to TipRanks’ Stock Analysis page.